A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/439 (2006.01) A61P 25/00 (2006.01) A61P 25/18 (2006.01) A61P 25/22 (2006.01) A61P 25/28 (2006.01)
Patent
CA 2649590
The invention relates to the use of a functional muscarinic M1/M4 agonist or a pharmaceutically acceptable salt thereof to treat prodromal syndrome and in the manufacture of a medicament for the treatment of prodromal syndrome, and to a method of treatment of prodromal syndrome using a functional muscarinic M1/M4 agonist or a pharmaceutically acceptable salt thereof. It also relates to the use of a pharmaceutical composition comprising a functional muscarinic M1/M4 agonist or a pharmaceutically acceptable salt thereof, and at least one cholinergic agent and/or at least one non-cholinergic agent for the treatment of prodromal syndrome, and to a method of treatment of prodromal syndrome by administration of a such a pharmaceutical composition.
L'invention porte sur l'utilisation d'un agoniste muscarinique M1/M4 fonctionnel ou d'un sel pharmaceutiquement acceptable de celui-ci dans le traitement d'un syndrôme prodromique et dans la fabrication d'un médicament traitant le syndrôme prodromique et un procédé de traitement d'un syndrome prodromique à l'aide d'un agoniste muscarinique M1/M4 fonctionnel ou d'un sel pharmaceutiquement acceptable de celui-ci. Elle porte également sur l'utilisation d'une composition pharmaceutique comprenant un agoniste muscarinique M1/M4 fonctionnel ou un sel pharmaceutiquement acceptable de celui-ci et au moins un agent cholinergique et/ou au moins un agent non cholinergique permettant le traitement d'un syndrôme prodromique et sur un procédé de traitement d'un syndrôme prodromique par l'administration d'une telle composition pharmaceutique.
Blower Peter Robin
Rasmussen Jill Galloway Chisnall
Sharpe Paul Christopher
Minster Research Limited
Smart & Biggar
LandOfFree
Mono and combination therapy with m1/m4 muscarinic agonist... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mono and combination therapy with m1/m4 muscarinic agonist..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mono and combination therapy with m1/m4 muscarinic agonist... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1848564